Related Experiment Videos
An internist's update on cholesterol management
Honey East Holman1, G Swink Hicks, Annette K Low
1Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505, USA. hholman@medicine.umsmed.edu
Insights
Coronary heart disease (CHD) is a leading cause of death, with cholesterol as a key risk factor. This review covers dyslipidemia classification, hyperlipidemia treatment, and emerging CHD risk factors.
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Coronary heart disease (CHD) is the primary cause of mortality in the United States.
- Cholesterol is recognized as a significant and modifiable risk factor for CHD development.
- Dyslipidemias, or abnormal blood lipid levels, are central to CHD pathogenesis.
Purpose of the Study:
- To provide a background on the classification of dyslipidemias.
- To discuss current guidelines for evaluating and treating hyperlipidemia.
- To explore other investigated risk factors associated with CHD.
Main Methods:
- Literature review of dyslipidemia classification.
- Analysis of current clinical practice guidelines for hyperlipidemia management.
- Synthesis of research on emerging CHD risk factors.
Main Results:
- Established classification systems for various dyslipidemias.
- Current evidence-based recommendations for lipid management.
- Identification of ongoing research into novel CHD risk factors.
Conclusions:
- Effective management of hyperlipidemia is crucial for reducing CHD mortality.
- Understanding dyslipidemia classification aids in targeted treatment strategies.
- Continued research is necessary to fully elucidate and address all CHD risk factors.
Abstract:
Coronary heart disease (CHD) remains the leading cause of death in the United States. It is now well established that cholesterol is an important, reversible risk factor for CHD. This article provides a brief background on classification of the dyslipidemias, then discusses current recommendations for the evaluation and treatment of hyperlipidemia. Other risk factors currently being investigated as they relate to the development of CHD are discussed.